BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30656537)

  • 21. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.
    Cheney SM; Andrews PE; Leibovich BC; Castle EP
    BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robot-assisted retroperitoneal lymph node dissection in testicular cancer.
    Abdul-Muhsin HM; L'esperance JO; Fischer K; Woods ME; Porter JR; Castle EP
    J Surg Oncol; 2015 Dec; 112(7):736-40. PubMed ID: 26351740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.
    Torricelli FC; Jardim D; Guglielmetti GB; Patel V; Coelho RF
    Int Braz J Urol; 2017; 43(1):171. PubMed ID: 28124545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
    Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
    J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
    Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
    World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer.
    Nason GJ; Kuhathaas K; Anson-Cartwright L; Jewett MAS; O'Malley M; Sweet J; Hansen A; Bedard P; Chung P; Hahn E; Warde P; Hamilton RJ
    J Robot Surg; 2022 Apr; 16(2):369-375. PubMed ID: 33982173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
    Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve-sparing Robot-assisted Retroperitoneal Lymph Node Dissection: The Monoblock Technique.
    Afferi L; Baumeister P; Fankhauser C; Mordasini L; Moschini M; Aschwanden F; Mattei A
    Eur Urol Open Sci; 2021 Oct; 32():1-7. PubMed ID: 34667953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
    Werntz RP; Pearce SM; Eggener SE
    Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.
    Luz MA; Kotb AF; Aldousari S; Brimo F; Tanguay S; Kassouf W; Aprikian AG
    World J Surg Oncol; 2010 Nov; 8():97. PubMed ID: 21062470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way.
    Bora GS; Panwar P; Mavuduru RS; Devana SK; Singh SK; Mandal AK
    J Robot Surg; 2017 Jun; 11(2):279-285. PubMed ID: 27503429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
    Ghoreifi A; Mitra AP; McClintock G; Baky F; McDowell Z; Lavallée E; Saoud R; Cai J; Gill IS; Sfakianos J; Porter J; Bagrodia A; Ahmadi N; Eggener S; Ward JF; Djaladat H
    Urol Oncol; 2023 Feb; 41(2):111.e7-111.e14. PubMed ID: 36437156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
    Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
    J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.